Concepedia

Karen E. Linder

KE

25

Publications

1.2K

Citations

18

H-Index

1986

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bracco (United States)

Bristol-Myers Squibb (Germany)

University of Pennsylvania

Washington University in St. Louis

Karen E. Linder is an author at Bristol-Myers Squibb (United States) specializing in inorganic chemistry, chemistry, and medicine.

Top concepts

Publications per year

1986–2020

25

Publications

25

177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.

Laura E. Lantry, Enrico Cappelletti, Mary Ellen Maddalena et al. · PubMed · 2006 · 175 citations

The Impact of Positron Emission Tomography with <sup>18</sup> F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial

Gerald L. Andriole, Lale Kostakoğlu, Albert Chau et al. · The Journal of Urology · 2018 · 148 citations · Full text

TcO(PnAO-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction

Karen E. Linder, Yee Wai Chan, John E. Cyr et al. · Journal of Medicinal Chemistry · 1994 · 120 citations

, , +18

Tuftsin Binds Neuropilin-1 through a Sequence Similar to That Encoded by Exon 8 of Vascular Endothelial Growth Factor

Mathew A. von Wronski, Natarajan Raju, Radhakrishna Pillai et al. · Journal of Biological Chemistry · 2005 · 119 citations · Full text

<sup>177</sup>Lu-AMBA Biodistribution, Radiotherapeutic Efficacy, Imaging, and Autoradiography in Prostate Cancer Models with Low GRP-R Expression

Mary Ellen Maddalena, Jaclyn Fox, Jianqing Chen et al. · Journal of Nuclear Medicine · 2009 · 84 citations · Full text

Rows per page

1–5 of 25